Humulin R Articles
Lilly launches diabetes drug Byetta in the UK
14 May 2007
Novo Nordisk's 1st-qtr 2007 profit rises 41%
14 May 2007
FDA approves Sanofi's Lantus SoloStar
7 May 2007
Japan stock market week to April 30, 2007
7 May 2007
Novo Nordisk opens Brazil insulin plant
7 May 2007
Generex in Middle East licensing deal for Oral-lyn
30 April 2007
Xenical boosts weight loss and cuts CV risk
30 April 2007
Pfizer's 1st-qtr profits tumble 17.5%
30 April 2007
Disposable insulin Nanopump from Debiotech and ST
30 April 2007
Lilly's 1st-qtr 2007 earnings drop 39%
23 April 2007
MediGene/JDRF in diabetes accord
16 April 2007
Pulmonary drug-delivery market to reach $34.5B by 2010
16 April 2007
No weight gain for "majority" on Levemir
16 April 2007
Stock Commentary - New York week to April 2
9 April 2007
FDA clears Janumet for type 2 diabetes
9 April 2007
Computer models to help patch drugs through skin
9 April 2007
Eli Lilly Japan's 2006 sales up 7% to $700M
2 April 2007
Polish biotech Bioton buys Biopartners
26 March 2007
Novo Nordisk growing in Japan
19 March 2007
Headlines 25 years ago this week....
5 March 2007
NovoSeven misses Ph III trial primary endpoint
5 March 2007
Mixed results from animal studies of CLA
5 March 2007
Novo Nordisk US hires Henrik Rasmussen
26 February 2007
Bentley's Nasulin to move into Ph II in India
26 February 2007
New study defends Cr picolinate in diabetes
19 February 2007
Novo's full-year 2006 net profit rises 10%
12 February 2007
Generex to initiate Ph III trial of Oral-lyn
7 February 2007
Levemir demonstrates safety and efficacy
7 February 2007
Exubera shows safety and efficacy
7 February 2007
Amylin/Lilly's Byetta comparable to insulin
7 February 2007
Takeda's Tandemact approved by EMEA
29 January 2007
Lilly halts Va insulin plant construction
22 January 2007
Daiichi Sankyo submits sNDA for WelChol
15 January 2007
Japan stock market week to Jan 8, 2007
15 January 2007
Lilly licenses PSN010 from OSI subsid
15 January 2007
World's "10 most promising" treatments
15 January 2007
SemBioSys proceeds with plant-produced insulin
8 January 2007
Novo's motion to block US Exubera denied
22 December 2006
Daily NovoSeven cuts bleed frequency 45%
22 December 2006
Encouraging weight loss findings for Levemir
18 December 2006
Lilly reiterates 2006/07 guidance, disappoints
18 December 2006
NovoMix 30 aids long-term glucose control
18 December 2006
Novartis' Galvus improves glucose control in elderly
18 December 2006
Japan stock market week to Dec 4, 2006
11 December 2006
Strong insulin control for Generex' Oral-lyn
11 December 2006
Novo Nordisk boosts US sales force
11 December 2006
Headlines 25 years ago this week....
4 December 2006
Resveratrol reduces fat and boosts endurance by activating SIRT1
27 November 2006
Strong animal data for Roche/Genmab's R1507
13 November 2006
Oramed signs manufacturing deal for oral insulin pill
13 November 2006
Bentley initiates Ph II trial of insulin nose spray
13 November 2006
Sanofi's Acomplia launched in Ireland
6 November 2006
Mixed results for Novo Nordisk in 3rd-qtr 2006
6 November 2006
Generics, including Plavix, and govt cost-cutting hit Sanofi-Aventis' 3rd-qtr results
6 November 2006
Cinnulin impresses in oxidative stress study
30 October 2006
Lilly's 3rd-qtr 2006 profit rises 10% on Zyprexa
30 October 2006
Counterfeit test strips found in USA
23 October 2006
Almirall and SPS announce 2006 pharmacology award
16 October 2006
CHMP positive about exenatide in diabetes
2 October 2006
EASD panels recommend insulin acceptance, and highlight shortfalls in DPNP therapy
25 September 2006
Bioton aims at 20% of Russian insulin market
25 September 2006
Novo Nordisk's liraglutide improves insulin secetion
25 September 2006
Exubera use not complicated by respiratory infections
25 September 2006
Technosphere could be next inhalable insulin on the market
25 September 2006
Unique benefits with Levemir and NovoRapid
25 September 2006
DREAM study results position GSK's Avandia as first-line treatment for type 2 diabetes
25 September 2006
Chromium added to antidiabetes treatment
25 September 2006
Japan stock market week to Sept 11, 2006
18 September 2006
Astellas screens target from Metabolex' gene database
18 September 2006
Japan stock market week to Sept 4, 2006
11 September 2006
Takeda's Actos reduces risk of recurrent stroke
11 September 2006
Branded biologic sales to plummet 60% by 2015
4 September 2006
Austrianova to explore possibilities in diabetes
4 September 2006
Nanogen granted six patents on diabetes and AD detection
4 September 2006
Aradigm granted continued Nasdaq listing
4 September 2006
Nutrition 21's Cr supps improve insulin control
14 August 2006
EC approves Takeda's antidiabetic Competact
14 August 2006
Bentley reports 2nd-qtr 2006 EPS of $0.12
14 August 2006
Emerging diabetes management solutions boost European market
14 August 2006
Takeda's Duetact get FDA OK for diabetes
7 August 2006
Pfizer sued by Novo for patent infringement
7 August 2006
Novo Nordisk's 1st-half 2006 sales rise 20%
7 August 2006
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
